Chapter 18. Protein Tyrosine Kinases and Cancer
- 1 January 1992
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 117 references indexed in Scilit:
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- The BCR gene encodes a novel serine/threonine kinase activity within a single exonCell, 1991
- Isolation and characterization of a neu protein-specific activating factor from human ATL-2 cell conditioned mediumBiochemical and Biophysical Research Communications, 1991
- A DIRECT APPROACH TOWARD THE SYNTHESIS OF ANALOGS OF ERBSTATINOrganic Preparations and Procedures International, 1991
- Effects of herbimycin A and various SH-reagents on p60v-src kinase activity invitroBiochemical and Biophysical Research Communications, 1990
- Selective inhibition of tyrosine protein kinase by a synthetic multisubstrate analogBiochemical and Biophysical Research Communications, 1989
- Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitorBiochemical and Biophysical Research Communications, 1989
- Irreversible inhibition of v-src tyrosine kinase activity by herbimycin a and its abrogation by sulfhydryl compoundsBiochemical and Biophysical Research Communications, 1989
- Specific inhibitors of tyrosine-specific protein kinase, synthetic 4-hydroxycinnamamide derivativesBiochemical and Biophysical Research Communications, 1987
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodiesCell, 1985